The plan was met with questions on why the vaccines are being sold and why any company is allowed to profit from it. - AFP
JAKARTA, July 12 (Reuters): An Indonesian pharmaceutical firm has postponed a plan to sell a Chinese Covid-19 vaccine directly to the public, amid criticism by health experts that such commercial schemes could bypass vulnerable groups in a country that promised free shots to all.
The decision came as coronavirus cases and deaths from the virus have hit record highs, pushing the healthcare system close to breaking point in parts of densely populated Java island.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
